| Literature DB >> 34568581 |
Pernille Axel Gregersen1,2,3, Mikkel Funding4, Jan Alsner1, Maja H Olsen5, Jens Overgaard1, Steen F Urbak4, Sandra E Staffieri6,7,8, Stina Lou9,10.
Abstract
OBJECTIVE: To explore living with heritable retinoblastoma, specifically survivors' perceived role of regular follow-up at a retinoblastoma survivorship clinic. METHODS AND ANALYSIS: Adult survivors of heritable retinoblastoma were recruited from the Retinoblastoma Survivorship Clinic, Aarhus University Hospital. Ten survivors participated in individual explorative, semistructured interviews. Thematic data analysis was conducted.Entities:
Keywords: genetics; retina
Year: 2021 PMID: 34568581 PMCID: PMC8438830 DOI: 10.1136/bmjophth-2021-000760
Source DB: PubMed Journal: BMJ Open Ophthalmol ISSN: 2397-3269
Interview guide
| Topic | Examples of questions |
| Everyday life | How would you say it affects your life today, that you had retinoblastoma (RB) as a child? |
| Heredity and cancer risk | When and how did you find out about the increased risk for other cancers? |
| Heredity and family | Who else in your family has RB and how has it—from your point of view—affected your family life? |
| Healthcare sector | What are the strengths and limitations of the way RB survivor care is organized? |
[text]: Explained in layman’s language.
*The full interview guide (in Danish) can be obtained from the first author on reasonable request.
Demographics, self-reported
| Topic | N (total 10) |
| Sex | |
| Female | 5 |
| Male | 5 |
| Age | |
| 20–29 | 3 |
| 30–39 | 5 |
| 40–49 | 1 |
| 50–59 | 0 |
| 60–69 | 1 |
| Laterality | |
| Unilat | 3 |
| Bilat | 7 |
| Educational level* | |
| Low | 2 |
| Medium | 0 |
| High | 8 |
| Married or in partnership | 7 |
| No of children | |
| 0 | 3 |
| 1 | 5 |
| 2 | 2 |
| 3 or more | 0 |
| Children with RB | 3 |
| Family history of RB | 5 |
| Second primary cancer | 2 |
*Educational level was according to the International Standard Classification of Education from Statistics Denmark (ISCED) grouped in three categories: low (1–10 years), medium (11–14 years) and high (>15 years).
RB, retinoblastoma.
Figure 1Five major themes and subthemes following thematic analysis.
Demographics, medical reports (treatment)
| Treatment | N (total 10) |
| Enucleation, unilat | 8 |
| Enucleation, bilat | 0 |
| Enucleation only | 3* |
| Radiotherapy, plaque | 1 |
| Radiotherapy, external beam | 7 |
| Chemotherapy | 1 |
*Enucleation as the only treatment only occurred in the three unilateral retinoblastoma survivors.
Demographics, medical reports (visual acuity)
| Best-corrected visual acuity | Right eye | Left eye |
| Unilateral | 1.6 | Enucleation |
| Unilateral | Enucleation | 1.25 |
| Unilateral | Enucleation | 1.25 |
| Bilateral | 1.0 | Enucleation |
| Bilateral | 1.0 | Hand movement |
| Bilateral | 0.16 | Enucleation |
| Bilateral | 0.8 | 0.63 |
| Bilateral | Enucleation | 0.5 |
| Bilateral | 1.25 | Enucleation |
| Bilateral | Enucleation* | 0.8 |
*Enucleation due to osteogenic sarcoma of the nasal cavity with involvement of the orbit.